Skip to main content
Yuyu Pharma, Inc. logo

Yuyu Pharma, Inc. — Investor Relations & Filings

Ticker · 000220 ISIN · KR7000220004 KO Manufacturing
Filings indexed 303 across all filing types
Latest filing 2024-09-12 Major Shareholding Noti…
Country KR South Korea
Listing KO 000220

About Yuyu Pharma, Inc.

https://www.yuyu.co.kr/

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Status of Large-Scale Shareholdings' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. This type of filing is commonly referred to as a '5% Rule' report or 'Major Shareholding Notification'. It details the share ownership, changes in holdings, and collateral agreements (stock-backed loans) of the major shareholder (Yoo Won-sang) and related parties of Yuyu Pharmaceutical. This fits the definition of a Major Shareholding Notification (MRQ).
2024-09-12 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Yuyu Pharma, covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial statements, business operations, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special related parties, including information on stock collateral and share acquisitions. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2024-07-22 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Yuyu Pharma. It details specific changes in share ownership for individuals identified as major shareholders or their relatives. In the context of financial filings, this type of disclosure regarding changes in ownership by major shareholders or insiders is classified as a Major Shareholding Notification.
2024-07-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (specifically Yuyu Pharmaceutical's major shareholder Yoo Won-sang and related parties) due to stock gifts and collateral loan adjustments. This falls under the 'Major Shareholding Notification' category.
2024-07-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report insider transactions, such as changes in share ownership by directors or major shareholders. According to the provided definitions, 'Director's Dealing' (DIRS) is the correct category for reports of personal share transactions by company directors and executives.
2024-07-03 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.